• 1
    Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Hemodialysis leukopenia; pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membrane. J Clin Invest 1977;59:87988.
  • 2
    Hakim RM, Breillatt J, Lazarus JM, Port IK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984; 311:87882.
  • 3
    Alvarez V, Pulido R, Campanero MR, Paraiso V. de Landozuri MO, Sanchez-Madrid K. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 1991;40:899905.
  • 4
    Craddock PR, Ferh J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977; 296:76974.
  • 5
    Craddock PR, Hammerschmidt DF, White JG, Dalmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism for complement mediated leukostasis and leukopenia. J Clin Invest 1977;60:26064.
  • 6
    Smeby LC, Wideroe TE, Blastad T, Jorstad S. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylnitrile. Polysulfone and polycarbonate hemodialyzers. Blood Purif 1986; 4: 93101.
  • 7
    Lee J. Hakim RM. Fearon DT. Increased expression of the C3b receptor by neutrophils and complement activation during hemodialysis. Clin Exp Immunol 1984;56:20514.
  • 8
    Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985;312:45762.
  • 9
    Himmelfarb J, Zaoui P, Hakim R. Modulation of granulocyte LAM-1 and Mac-1 during dialysis—a prospective, randomized controlled trial. Kidney Int 1992;41:38898.
  • 10
    Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C, Bacle F, Delons S, Kazatchkine MD. In-vivo induction of interleukin-1 during hemodialysis. Kidney Int 1989;35:12128.
  • 11
    Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor a. Kidney Int 1990; 37: 11625.
  • 12
    Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37:8593.
  • 13
    Lonnemann G, Bingel M, Floege J. Detection of endotoxin-like interleukin-1 inducing activity during in vitro dialysis. Kidney Int 1988; 33;2935.
  • 14
    Luger A, Kovarik J, Stummvoll HK, Urbanska A, Luger TA. Blood–membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32:8488.
  • 15
    Betz M, Haensch GM, Rauterberg EW, Bommer J, Ritz E. Cuproammonium membranes stimulate inierleukin-1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int 1988; 34:6773.
  • 16
    Hörl WH, Steinhauer HB, Schollmeyer P. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int 1985; 28:7916.
  • 17
    Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret C. Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985; 28:1587.
  • 18
    Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991; 17:2716.
  • 19
    Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM. Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Soc Nephrol 1993;4:17886.
  • 20
    Cappelliere-Blandin C, Delaveau T, Descamps-Latscha B. Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals. Biochem J 1991;277:17582.
  • 21
    Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983;130:191017.
  • 22
    Himmelfarb J, Hakim R, Holbrook D, Leeber D, Ault K. Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry 1992; 13:8389.
  • 23
    Rosenkranz AR, Schmaldienst S, Stuhlmeier KM, Chen W. Knapp W, Zlabinger GJ. A microplate assay for the detection of oxidative products using 2′.7′-dichlorofluorescin-diacetate. J Immunol Methods 1992; 156: 3945.
  • 24
    Rosenkranz AR, Majdic O, Stöckl J, Pickl W, Stockinger H, Knapp W. Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface siaioglycoprotein restricted to haemopoietic cells. Immunology 1993; 80;4318.
  • 25
    Zlabinger GJ, Rosenkranz AR, Schmaldienst S, et al. Reactive oxygen product formation after Fcγ, receptor-mediated neutrophil activation by monomeric mouse IgG2a: implications for the generation of first close effects after OKT3 treatment. Eur J Immunol 1993; 23:97780.
  • 26
    Amadori A, Candi P, Sasdelli M, et al. Hemodialysis leucopenia and complement function with different dialyzers. Kidney Int 1983; 24:77581.
  • 27
    Chenoweth DE, Chung AK, Ward DM, Henderson LW. Anaphylatoxine formation during hemodialysis: effect of different dialyzer membranes. Kidney Int 1983; 24:7704.
  • 28
    Haag-Weber M, Schollmeyer P, Hörl WH. Granulocyte activation during hemodialysis in the absence of complement activation: inhibition of calcium channel blockers. Eur J Clin Invest 1985;18:3805.
  • 29
    de Vineusa SG, Resano M, Luno J et al. Leucopenia, hypoxia and complement activation in hemodialysis. Three unrelated phenomena. Proc Eur Dial Transplant Assoc 1982; 19: 15967.
  • 30
    Wiegmann TB, MacDougall ML, Diederich DA. Dialysis leucopenia, hypoxemia and anaphylatoxine formation: effect of membrane, path and citrate anticoagulation. Am J Kidney Dis 1988; 11:41824.
  • 31
    Guerro IC, Schreiber AD, McGregor RR. Studies of the plasma factors which induce augmented granulocyte adherence during hemodialysis. Nephron 1981;27:7983.
  • 32
    Cheung AK, Parker CJ, Hohnholt M. β2 integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney Int 1993; 43:64960.
  • 33
    Kuwahara T, Markert M, Wauters JP. Neutrophil oxygen radical production by dialysis membranes. Nephrol Dial Transplant 1988;3:6615.
  • 34
    Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-k, B transcription factor and HIV-I. EMBO J 1991; 10:224758.
  • 35
    Patel KD, Zimmermann GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991; 112:74959.
  • 36
    Hattori R, Hamilton KK, McEver RP, Sims PJ. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand Factor and translocation of granule membrane protein GMP-140 lo the cell surface. J Biol Chem 1989;264:905360.
  • 37
    Willems J, Joniau M, Cinque S, Van Damme J. Human granulocytic chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines. Immunology 1989;67:540.
  • 38
    Baggiolini M, Walz A, Kunkei S. Neutrophil-activating peptide 1/inicrleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045.
  • 39
    Daniels RH, Finnen MJ, Hill ME, Lackie JM. Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A; activation in human neutrophils. Immunology 1992; 75:15763.
  • 40
    Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: a critical survey. Kidney Int 1993; 43:S135S142.
  • 41
    Powell AC, Bland LA, Oettinger CW et al. Lack of plasma interleukin-1β or tumor necrosis factor-α elevation during unfavorable hemodialysis conditions. J Am Soc Nephrol 1991; 2:100713.